Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
O’Brien MF, Stafford EG, Gardner MA, Pohlner PG, McGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812–823.
Angell WW, Angell JD, Oury JH, Lamberti JJ, Grehl TM. Long-term follow-up of viable frozen aortic homografts: a viable homograft valve bank. J Thorac Cardiovasc Surg 1987;93:815–822.
Hammermeister KE, Sethi GK, Henderson WG. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 1993;328(18): 1289–1296.
Jones EL, Shah VB, Shanewise, et al. Should the freehand allograft be abandoned as a reliable alternative for aortic valve replacement? Ann Thorac Surg 1995;59:1397–1404.
Doty DB, Michielon G, Wang N. Replacement of the aortic valve with cryopreserved aortic allograft. Ann Thorac Surg 1993;56:228–236.
Clarke D, Campbell D, Hayward A, et al. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 1993;105:934–942.
Clarke DR, Bishop DA. Allograft degeneration in infant pulmonary valve allograft recipients. EJCTS 1993;7:365–370.
Kirklin JK, Smith D, Novick W, et al. Long-term function of cryopreserved aortic homografts: a ten year study. J Thorac Cardiovasc Surg 1993; 106:154–166.
Clarke DR. Extended aortic root replacement with cryopreserved allografts: do they hold up? Ann Thorac Surg 1991;52:669–673; discus.
Mohri H, Reichenbach DD, Barnes RW, Nelson RJ, Merendino KA. Studies of antigenicity of the homologous aortic valve. J Thorac Cardiovasc Surg 1967;54:564–572.
Baue AE, Donawick WJ, Blakemore WS. The immunologic response to heterotopic allovital aortic valve transplants in presensitized and non-sensitized recipients. J Thorac Cardiovasc Surg 1968;56:775–789.
Buch WS, Kosek JC, Angell WW. The role of rejection and mechanical trauma on valve graft viability. J Thorac Cardiovasc Surg 1971;5:696–706.
Thiede A, Timm C, Burnhard A, et al. Studies on the antigenicity of vital allogeneic valve leaflet transplants in immunogenetically controlled strain combinations. Transplantation 1978;26: 391–395.
el Khatib H, Lupinetti FM. Antigenicity of fresh and cryopreserved rat valve allografts. Transplantation 1990;49:765–767.
Lupinetti FM, Cobb S, Kioschos HC, Thompson SA, Walters KS, Moore KC. Effect of immunological differences on rat aortic valve allograft calcification. J Card Surg 1992;7:65–70.
Gonzales-Lavin L, Bianchi J, Graf D, Amini S, Gordon CL. Degenerative changes in fresh aortic root homografts in a canine model: evidence of an immunologic influence. Transplant Proc 1988;20:815–819.
Zhao X, Green M, Frazer IH, et al. Donor-specific immune response after aortic valve allografting in the rat. Ann Thorac Surg 1994;57: 1158–1163.
Balch CM, Karp RB. Blood group compatibility and aortic valve allotransplantation in man. J Thorac Cardiovasc Surg 1975;70:256–259.
Salomon RN, Friedman GB, Callow AD, et al. Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplantation antigens. J Thorac Cardiovasc Surg 1993;106:1173–1180.
Yacoub M, Suitters A, Khaghani A, et al. Localization of major histocompatability complex (HLA, ABC, and DR) antigens in aortic homografts. In Bodnar E, Yacoub M (eds). Biologic and bioprosthetic valves. New York: Yorke Medical Books; 1986:65–72.
Simon A, Zavazava N, Sievers H, et al. In vitro cultivation and immunogenicity of human cardiac valve endothelium. J Card Surg 1993;8: 656–665.
Hoekstra F, Knoop C, Aghai Z, et al. Stimulation of immune-competent cells in vitro by human cardiac valve-derived endothelial cells. Ann Thorac Surg 1995;60:S131–S134.
Johnson CM, Fass DN. Porcine cardiac valvular endothelial cells in culture. A relative deficiency of fibronectin synthesis in vitro. Lab Invest 1983; 49:589–597.
Lupinetti FM, Tsai TT, Kneebone JM. Endothelial cell replication in an in vivo model of aortic allografts. Ann Thorac Surg 1993;56:237–241.
Schoen FJ, Mitchell RN, Jonas RA. Pathological considerations in cryopreserved allograft heart valves. J Heart Valve Dis 1995;4:S72–S76.
Yankah AC, Muller-Hermelink HK, Muller-Ruchholtz W, et al. Antigenitat allogener Herzklappen. Z Herz Thorax GefaBchir 1992;6:41–47.
Muller-Hermelink HK, Muller-Ruchholtz W, et al. Antigentat allograft explants. In Yankah AC, Hetzer R, Miller DC, Ross DN, Sommerville J, Yacoub HM (eds). Cardiac valve allografts 1962–1987. New York: Steinkopff, Darmstadt, Springer; 1989.
Lupinetti FM, King DM, Khatib HE, et al. Immunogenicity of aortic valve allografts does not correlate with presence of antigen. J Am Coll Cardiol 1991;17:213A.
Schutz A, Fischlein T, Breuer M, et al. Cytoimmunological monitoring after homograft valve replacement. Eur J Cardio-thorac Surg 1994;8: 609–612.
Jutte NHPM, Hop WCJ, Daane R, et al. Cytoimmunological monitoring of heart transplant recipients. Clin Trans 1990;4:297–300.
Hoekstra F, Knoop C, Vaessen L, et al. Donor-specific immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg 1997; in press.
Khatib HE, Thompson SA, Lupinetti FM. Effect of Storage at 4C in a Nutrient Medium on Antigenic Properties of Rat Aortic Valve Allografts. The Society of Thoracic Surgeons 1990;49:792–796.
Lang SJ, Giordano MS, Cardon-Cardo C, et al. Biochemical and cellular characterization of cardiac valve tissue after cryopreservation or antibiotic preservation. J Thorac Cardiovasc Surg 1994;108:63–67.
VanDerKamp AWM, Visser WJ, van Dongan JM, Nauta J, Galjaard H. Preservation of aortic heart valves with maintenance of cell viability. J Surg Res 1981;30:47.
Lupinetti FM, Tsai T, Kneebone J, et al. Effect of cryopreservation on the presence of endothelial cells on human valve allografts. J Thorac Cardiovasc Surg 1993;106:912–917.
Yankah AC, Wottge HU, Muller-Hermelink HK, Feller AC, Lange P, Wessel U, Dreyer H, Bernhard A, Müller-Ruchholtz W. Transplantation of aortic and pulmonary allografts,enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J Card Surg 1987;2:209–220.
Pober JS, Collins T, Gimbrone MAJr, et al. Inducible expression of class II major histocompatability complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986;41:141–146.
Lodge PA, Haisch CE. T-cell subset responses to allogenic endothelium. Transplantation 1993;56: 656–661.
Hengstenberg C, Rose ML, Page C, et al. Immunocytochemical changes suggestive of damage to endothelial cells during rejection of human cardiac allografts. Transplantation 1993; 49:895–899.
Theobald VA, Lauer JD, Kaplan FA, et al. “Neutral allografts”—lack of allogeneic stimulation by cultured human cells expressing MHC Class I and Class II antigens. Transplantation 1993;55:128–133.
Jutte NHPM, Heijse P, Van Batenburg, et al. Donor heart endothelial cells as targets for graft infiltrating lymphocytes after clinical cardiac transplantation. Transplant Immuno 1993;1:39–44.
Moraes JR, Stastney P. A new antigen system expressed in endothelial cells. J Clin Invest 1977; 60:449–453.
Claas FHJ, Paul LC, van Es LA, et al. Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts. Tissue Antigens 1980;15:19–25.
Cochran RP, Kunzelman KS. Cryopreservation does not alter antigenic expression of aortic allografts. J Surg Res 1989;46:597–599.
Douglas Calhoun A, Baur GM, Porter JM, et al. Fresh and cryopreserved venous allografts in genetically characterized dogs. J Surg Res 1977; 22:687–696.
Jonas RA, Ziemer G, Britton L, Armiger LC. Cryopreserved and fresh antibiotic-sterilized valved aortic homograft conduits in a long-term sheep model. Hemodynamic, angiographic, and histologic comparisons. J Thorac Cardiovasc Surg 1988;96:746–755.
Hoekstra F, Knoop C, Jutte, et al. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant 1994; 13:1095–1098.
Quigly RL, Switzer SS, Victor A, et al. Modulation of alloreactivity in transplant recipients by phenotypic manipulation of donor endothelium. J Thorac Cardiovasc Surg 1995;109:905–909.
Johnson CM, Nyberg Hanson M, Helgeson SC. Porcine cardiac valvular endothelial cells in culture: cell isolation and growth characteristics. J Mol Cell Cardiol 1987;19:1185–1193.
Bandlien KO, Toledo-Pereyra LH, Barnhart MI, et al. Improved survival of venous allografts in dogs following graft pretreatment with cyclosporine. Transplant Proc 1983;4:3084–3091.
Young WP, Rowe GG. A study of aortic regurgitation in aortic-valve homografts. Ann Thorac Surg 1968;6:11–15.
Neves J, Monteiro C, Santos R, et al. Histologic and genetic assessment of explanted allograft valves. Ann Thorac Surg 1995;60:141–145.
Augelli NV, Lupinetti FM, Khatib H, Sanofsky SJ, Rossi NP. Allograft vein patency in a canine model. Additive effects of cryopreservation and cyclosporine. Transplantation 1991;52:466–470.
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Hoekstra, F., Knoop, C., Bogers, A., Weimar, W. (2005). Activation of the Immune System by Cardiac Valve Allografts. In: Cardiac Reconstructions with Allograft Tissues. Springer, New York, NY. https://doi.org/10.1007/0-387-26515-5_15
Download citation
DOI: https://doi.org/10.1007/0-387-26515-5_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-94962-8
Online ISBN: 978-0-387-26515-5
eBook Packages: MedicineMedicine (R0)